Jodie Morrison P.'s Insider Trades & SAST Disclosures
Jodie Morrison P.'s most recent trade in Q32 Bio Inc. was a trade of 394,445 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jodie Morrison P..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | P. Jodie Morrison | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 394,445 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | P. Morrison Jodie | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 394,445 | 394,445 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | P. Jodie Morrison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 152,700 | 152,700 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Jodie Morrison P. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 152,700 | 152,700 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Jodie P. Morrison | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 152,700 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Morrison P. Jodie | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 152,700 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Jodie Morrison P. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 132,000 | 132,000 | - | 0 | Common Stock | |
| Q32 Bio Inc. | P. Jodie Morrison | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 16,901 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | P. Jodie Morrison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 16,901 | 16,901 | - | - | Stock Option (Right to Buy) | |
| Verve Therapeutics Inc | Jodie P. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 267,541 | 267,541 | - | - | Stock Option (right to buy) | |
| Q32 Bio Inc. | Jodie P. Morrison | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 394,445 | 394,445 | - | - | Stock Option (Right to Buy) | |
| Rein Therapeutics Inc. | Jodie P. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Jodie P. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges